Rp-HPLC Determination of Quercetin in a Novel D-α-Tocopherol Polyethylene Glycol 1000 Succinate Based SNEDDS Formulation: Pharmacokinetics in Rat Plasma
Regardless of its confirmed efficacy in various metabolic issues, quercetin (QU) for medical use remains to be restricted due to its low bioavailability. D-α-Tocopherol polyethylene glycol 1000 succinate (TPGS) is authorised as a protected pharmaceutical adjuvant with marked antioxidant and anti inflammatory actions. Within the present examine, a number of QU-loaded self-nanoemulsifying drug supply programs (SNEDDS) have been investigated to enhance QU bioavailability. A reversed part excessive efficiency liquid chromatography (RP-HPLC) methodology was developed, for the primary time, as a easy and delicate method for pharmacokinetic research of QU within the presence of TPGS SNEDDS formulation in rat plasma. The analyses have been carried out on a Xterra C18 column (4.6 × 100 mm, 5 µm) and UV detection at 280 nm.
The analytes have been separated by a gradient system of methanol and phosphate buffer of pH 3. The developed RP-HPLC methodology confirmed low restrict of detection (LODs) of seven.65 and 22.09 ng/mL and LOQs of 23.19 and 66.96 ng/mL for QU and TPGS, respectively, which allowed their willpower in actual rat plasma samples. The tactic was linear over a variety, (30-10,000) and (100-10,000) ng/mL for QU and TPGS, respectively. The chosen SNEDDS formulation, containing 50% w/w TPGS, 30% polyethylene glycol 200 (PEG 200), and 20% w/w pumpkin seed oil (PSO), confirmed a globule measurement of 320 nm and -28.6 mV zeta potential. Outcomes of the pharmacokinetic research confirmed 149.8% enchancment in bioavailability of QU in SNEDDS relative to its suspension. The developed HPLC methodology proved to be easy and delicate for QU and TPGS simultaneous willpower in rat plasma after oral administration of the brand new SNEDDS formulation.
Towards Physicochemical and Rheological Characterization of Totally different Injectable Hyaluronic Acid Dermal Fillers Cross-Linked with Polyethylene Glycol Diglycidyl Ether
(1) Background: Injectable hyaluronic acid (HA) dermal fillers are used to revive quantity, hydration and pores and skin tone in aesthetic medication. HA fillers differ from one another attributable to their cross-linking applied sciences, with the purpose to extend mechanical and organic actions. Some of the latest and promising cross-linkers is polyethylene glycol diglycidyl ether (PEGDE), utilized by the corporate Matex Lab S.p.A., (Brindisi, Italy) to create the HA dermal filler PEGDE household. Over the previous few years, a number of research have been carried out to research the biocompatibility and biodegradability of those formulations, however little info is accessible relating to their matrix construction, rheological and physicochemical properties associated to their cross-linking applied sciences, the HA content material or the diploma of cross-linking.
(2) Strategies: Seven completely different injectable HA hydrogels have been subjected to optical microscopic examination, cohesivity analysis and rheological characterization with a view to examine their conduct.
(3) Outcomes: The analyzed cross-linked dermal fillers confirmed a fibrous “spiderweb-like” matrix construction, with every medical machine presenting completely different and peculiar rheological options. Aside from HA non cross-linked hydrogel 18 mg/mL, all confirmed an elastic and cohesive profile.
(4)Conclusions: The comparative evaluation with different literature works makes a preliminary characterization of those injectable medical units attainable.
In vivo measurement of distance between scapular neck and polyethylene insert throughout lively exterior rotation in shoulders with Grammont sort reverse prosthesis
Background: Scapular notching is a incessantly noticed complication after reverse shoulder arthroplasty. Impingement of the humeral plastic insert towards the scapular neck is believed to be the reason for notching. There have been no in vivo research that analyzed the positional relationship between the scapular neck and humeral insert. The aim of this examine was to measure the space between the scapular neck and insert in shoulders with Grammont-type prostheses throughout lively exterior rotation on the facet.
Strategies: Eighteen shoulders with Grammont-type prostheses have been enrolled on this examine. There have been 13 males and 5 females, and the imply age at surgical procedure was 74 years (vary, 63-91). Fluoroscopic photos have been recorded throughout lively exterior rotation on the facet from most inner to exterior rotation at a mean of 14 months (vary, 7-24) after surgical procedure. Implant kinematics have been decided with three-dimensional fashions of the implants and fluoroscopic photos utilizing model-image registration strategies. Based mostly on the implant kinematics, the closest distance between the scapular neck and insert was computed at every 5° increment of glenohumeral inner/exterior rotation.
Outcomes: Imply glenohumeral abduction throughout rotation was 17°-22°. The imply distance between the neck and insert was roughly 1 mm all through the exercise. The separation distance tended to slender with arm exterior rotation, however the change was not vital.
Interpretation: The small distance between the scapular neck and insert in early post-operative reverse shoulder arthroplasty sufferers could also be related with the excessive incidence of scapular notching in Grammont-type prostheses.
Willpower of low-density polyethylene-water partition coefficients for novel halogenated flame retardants with the massive quantity mannequin and co-solvent mannequin
The partition coefficient (Okpew) of an analyte between low-density polyethylene (LDPE) movie and water is a important parameter for measuring freely dissolved concentrations of the analyte with PE passive sampling units. Measuring log Okpew for tremendous hydrophobic natural chemical compounds (HOCs) have been confirmed extraordinarily tough. The current examine developed a big quantity mannequin for measuring log Okpew of tremendous HOCs, i.e., novel halogenated flame retardants (NHFRs). Outcomes confirmed that the measured log Okpew values of chosen PAHs and PCBs obtained by the massive quantity mannequin have been according to these from the co-solvent mannequin and the literature information inside much less 0.Three log models of distinction, whereas these of NHFRs (6.27-7.34) apart from hexachlorocyclopentadienyldibromocyclooctane (HCDBCO) and Decabromodiphenyl ethane (DBDPE) have been considerably decrease than these (6.51-8.89) from the co-solvent mannequin.
A curvilinear relationship was noticed between log Okpew and log Okow of all goal compounds, with the turning level at log Okow = ∼8.Zero within the massive quantity mannequin, however that was not discovered for the co-solvent mannequin. These might be attributed to the massive molecular volumes (> 450 Å3) for NHFRs, which require excessive Gibbs free vitality to penetrate into the within buildings of LDPE within the massive quantity mannequin. Nonetheless, the solvent swelling results within the co-solvent mannequin must be investigated. Due to this fact, the massive quantity mannequin is powerful to find out the Okpew values of tremendous HOCs for facilitating the applying of aquatic passive sampling strategies
Analytical strategies for the investigation of enzyme-catalyzed degradation of polyethylene terephthalate
The polyester PET (poly(ethylene terephthalate)) plastic is chemically inert and remarkably persistent, posing related and international air pollution considerations attributable to its accumulation in ecosystems throughout the globe. In previous years, analysis targeted on figuring out micro organism lively on PET and on the precise enzymes answerable for its degradation. Right here, the enzymatic degradation of PET might be thought-about as an “erosion course of” that takes place on the floor of an insoluble materials and leads to an uncommon, substrate-limited kinetic situation. On this evaluation, we report on probably the most appropriate fashions to guage the kinetics of PET-hydrolyzing enzymes, which takes into consideration the quantity of enzyme adsorbed on the substrate, the enzyme-accessible ester bonds, and the product inhibition results.
Cautious kinetic evaluation is particularly related to match enzymes from completely different sources and developed variants generated by protein engineering research as effectively. Moreover, the analytical strategies best suited to display pure micro organism and recombinant variant libraries generated by protein engineering have been additionally reported. These strategies depend on completely different detection programs and are carried out each on mannequin compounds and completely different PET samples (e.g., nanoparticles, microparticles, and waste merchandise). All this significant info represents an optimum start line and boosts the method of figuring out programs in a position to biologically recycle PET waste merchandise.
Polyethylene eye-cover versus synthetic teardrops within the prevention of ocular floor illnesses in comatose sufferers: A potential multicenter randomized triple-blinded three-arm medical trial
Background: Polyethylene covers are claimed to be helpful in stopping ocular floor illnesses (OSD); nonetheless, proof of their medical efficacy is proscribed. This medical trial aimed to match using polyethylene eye covers and synthetic teardrops versus regular saline on the incidence and severity of OSD in comatose sufferers.
Strategies: Of 90 eligible sufferers randomly assigned to 3 remedy teams, 79 sufferers accomplished the examine, In group A, sufferers (n = 25) obtained synthetic teardrops for left and regular saline for proper eyes, in group B (n = 29) polyethylene covers for left and regular saline for proper eyes, and in group C (n = 25) polyethylene covers for left and synthetic teardrops for proper eyes. Because the sufferers have been comatose, their blinding didn’t relevant, and a blinded observer evaluated the sufferers’ eyes based mostly on the Corneal Fluorescein Staining Sample. The blinded analyzer analyzed collected information by SPSS-16 software program at a 95% confidential degree.
Outcomes: The OSDs have been noticed in 65 (41.14%) out of 158 eyes examined. The unreal teardrop was more practical than the conventional saline in group A, polyethylene eye cowl was extra helpful than the conventional saline in group B, and polyethylene eye cowl was more practical than the unreal teardrop in group C in lowering the incidence of OSD (p< 0.01). Polyethylene eye covers had probably the most affect on lowering the severity of the OSD in comparison with the opposite interventions (p< .001).
Conclusions: Polyethylene eye covers considerably decreased the incidence and severity of OSD. Utilizing polyethylene cowl is recommended as a protected, efficient, and accessible eye care intervention for stopping OSD in comatose sufferers.
A Medial Congruent Polyethylene Provides Passable Early Outcomes and Affected person Satisfaction in Whole Knee Arthroplasty
Background: Though a profitable operation, virtually 20% of sufferers are dissatisfied with whole knee arthroplasty (TKA). The aim of this retrospective cohort examine was to see if a medial congruent (MC) polyethylene would provide passable early outcomes and affected person satisfaction after TKA.
Strategies: We reviewed prospectively collected information on 327 TKAs utilizing a number of bearings inside the identical implant system. Ninety-six obtained an MC bearing, 70 obtained a cruciate-retaining (CR) bearing, and 161 obtained a posterior-stabilized (PS) bearing. We evaluated the visible analog scale ache scores and vary of movement (ROM) at 2 weeks, 6 weeks, Three months, and 1 yr; Affected person-Reported Outcomes Measurement Info System (PROMIS-10) rating and Knee Harm and Osteoarthritis End result Rating (KOOS) at Three months and 1 yr; and Forgotten Joint Rating (FJS-12) at 1 yr.
Outcomes: All teams had related KOOS and PROMIS-10 scores. MC knees had decrease visible analog scale scores than PS knees in any respect time factors (P < .05) and the next ROM than PS at 2 weeks (98.6 vs 93.7, P = .002). MC knees had a considerably greater FJS-12 than CR knees (71.6 vs 58.7, P = .02). Extra MC knees have been “very glad” than CR (92.6% vs 81.5%, P = .04). Fewer MC knees have been “in no way glad” than CR (1.2% vs 9.2%, P = .04). There have been related satisfaction rankings with MC and PS.
Conclusions: An MC bearing supplied related or improved early ache, ROM, KOOS, PROMIS-10, FJS-12, and affected person satisfaction as in contrast with normal bearings in TKA.
 Anti-Integrin alpha 5/ITGA5 Antibody |
|||
| PB9254 | BosterBio | 100ug/vial | EUR 294 |
|
Anti-Integrin alpha 5/ITGA5 Antibody |
|||
| A01911 | BosterBio | 100ug/vial | EUR 334 |
 Alpha V Beta 5 Integrin, Peptide Aptamer, Biotinylated |
|||
| AP-301-B | Alpha Diagnostics | 1 mg | Ask for price |
 Alpha V Beta 5 Integrin, Peptide Aptamer, unlabeled |
|||
| AP-301-U | Alpha Diagnostics | 5 mg | Ask for price |
 Integrin alpha-5 Antibody |
|||
| abx234347-100ug | Abbexa | 100 ug | EUR 509 |
 Integrin alpha 5 Antibody |
|||
| 49269-100ul | SAB | 100ul | EUR 333 |
|
Integrin alpha 5 Antibody |
|||
| 49269-50ul | SAB | 50ul | EUR 239 |
 Anti-Integrin alpha 5 Rabbit Monoclonal Antibody |
|||
| M01911 | BosterBio | 100ug/vial | EUR 397 |
|
Description: Rabbit Monoclonal Integrin alpha 5 Antibody. Validated in IP, IF, WB and tested in Human, Mouse, Rat. |
|||
 Alpha V Beta 5 Integrin, Peptide Aptamer, FITC labelled |
|||
| AP-301-F | Alpha Diagnostics | 1 mg | Ask for price |
 Protein) Human Integrin Alpha 5 (ITGa5) Protein |
|||
| 20-abx067272 | Abbexa |
|
|
 anti-Integrin beta 5 |
|||
| YF-PA12792 | Abfrontier | 100 ug | EUR 403 |
|
Description: Rabbit polyclonal to Integrin beta 5 |
|||
|
anti-Integrin beta 5 |
|||
| YF-PA24023 | Abfrontier | 50 ul | EUR 334 |
|
Description: Mouse polyclonal to Integrin beta 5 |
|||
) Recombinant Integrin Alpha 5 (ITGa5) |
|||
| 4-RPB287Bo01 | Cloud-Clone |
|
|
|
Description: Recombinant Bovine Integrin Alpha 5 expressed in: E.coli |
|||
|
Recombinant Integrin Alpha 5 (ITGa5) |
|||
| 4-RPB287Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Integrin Alpha 5 expressed in: E.coli |
|||
|
Recombinant Integrin Alpha 5 (ITGa5) |
|||
| 4-RPB287Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Integrin Alpha 5 expressed in: E.coli |
|||
 Antibody) Integrin Alpha 5 (ITGa5) Antibody |
|||
| 20-abx129339 | Abbexa |
|
|
 Antibody) Integrin Alpha 5 (ITGA5) Antibody |
|||
| 20-abx113185 | Abbexa |
|
|
|
Integrin Alpha 5 (ITGA5) Antibody |
|||
| 20-abx323564 | Abbexa |
|
|
|
Integrin Alpha 5 (ITGA5) Antibody |
|||
| 20-abx338742 | Abbexa |
|
|
|
Integrin Alpha 5 (ITGa5) Antibody |
|||
| 20-abx101634 | Abbexa |
|
|
|
Integrin Alpha 5 (ITGa5) Antibody |
|||
| 20-abx101635 | Abbexa |
|
|
|
Integrin Alpha 5 (ITGA5) Antibody |
|||
| 20-abx000873 | Abbexa |
|
|
|
Integrin Alpha 5 (ITGA5) Antibody |
|||
| 20-abx006811 | Abbexa |
|
|
|
Integrin Alpha 5 (ITGA5) Antibody |
|||
| abx011678-100ul | Abbexa | 100 ul | EUR 411 |
|
Integrin Alpha 5 (ITGA5) Antibody |
|||
| abx026655-400ul | Abbexa | 400 ul | EUR 523 |
|
Integrin Alpha 5 (ITGA5) Antibody |
|||
| abx026655-80l | Abbexa | 80 µl | EUR 286 |
 Integrin alpha 5 Rabbit mAb |
|||
| A19069-100ul | Abclonal | 100 ul | EUR 410 |
|
Integrin alpha 5 Rabbit mAb |
|||
| A19069-200ul | Abclonal | 200 ul | EUR 571 |
|
Integrin alpha 5 Rabbit mAb |
|||
| A19069-20ul | Abclonal | 20 ul | EUR 221 |
|
Integrin alpha 5 Rabbit mAb |
|||
| A19069-50ul | Abclonal | 50 ul | EUR 287 |
|
Integrin Alpha 5 (ITGa5) Antibody |
|||
| 20-abx179024 | Abbexa |
|
|
|
Integrin Alpha 5 (ITGa5) Antibody |
|||
| 20-abx172956 | Abbexa |
|
|
 Antibody) Integrin alpha 5 (CD49e) Antibody |
|||
| abx216264-100ug | Abbexa | 100 ug | EUR 439 |
|
Integrin Alpha 5 (ITGA5) Antibody |
|||
| 20-abx327245 | Abbexa |
|
|
|
Integrin Alpha 5 (ITGA5) Antibody |
|||
| 20-abx325454 | Abbexa |
|
|
 Integrin alpha 5 Conjugated Antibody |
|||
| C49269 | SAB | 100ul | EUR 397 |
 Antibody) Integrin alpha 5 (CD49e) Antibody |
|||
| AF5200 | Affbiotech | 200ul | EUR 304 |
|
Description: Integrin α5 (CD49e) Antibody detects endogenous levels of total Integrin α5 (CD49e). |
|||
 Integrin alpha-5 Recombinant Protein |
|||
| 91-433 | ProSci | 0.05 mg | EUR 542.75 |
|
Description: Integrin alpha-5 belongs to the Integrin alpha chain family and contains 7 FG-GAP repeats. Integrin alpha-5 joins with Integrin- beta 1 to form a fibronectin and laminin receptor which recognizes the sequence R-G-D in its ligands. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. It is expressed on fibroblasts, endothelial cells, peripheral T cells and platelets. Integrin alpha-5 undergoes post-translational cleavage in the extracellular domain to yield disulfide-linked light and heavy chains. In addition to adhesion, ITGA5 participates in cell-surface mediated signalling. |
|||
,antiserum #1) Rabbit Anti-Human Alpha Defensin 5 (NP-5),antiserum #1 |
|||
| HDEFA51-S | Alpha Diagnostics | 100 ul | EUR 457 |
 Anti-Integrin alpha antibody |
|||
| STJ96613 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alpha4. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ96825 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alphaD. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ97273 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alphaL. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ97283 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alpha2. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ97284 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Integrin alpha5 is a protein encoded by the ITGA5 gene which is approximately 114,5 kDa. Integrin alpha5 is localised to the cell membrane and is involved in the MAPK-Erk pathway, apoptotic pathways, integrin pathway, focal adhesion and blood-brain barrier and immune cell transmigration. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signalling. Integrin alpha5 is expressed in the liver, lung, nervous system, bone marrow and blood. Mutations in the ITGA5 gene may result in colon carcinoma and congenital epulis STJ97284 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This polyclonal antibody detects endogenous levels of Integrin alpha5 protein. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ97285 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alpha6. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ97657 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alpha3. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ98181 | St John's Laboratory | 100 µl | EUR 234 |
|
Description: Mouse monoclonal to Integrin alpha5. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ98510 | St John's Laboratory | 100 µl | EUR 234 |
|
Description: Mouse monoclonal to Integrin alpha5. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ98511 | St John's Laboratory | 100 µl | EUR 234 |
|
Description: Mouse monoclonal to Integrin alpha6. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ98709 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alpha1. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ98737 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alphaX. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ93727 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alpha3. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ93728 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alpha4. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ93729 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alphaE. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ93730 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alphaV. |
|||
|
Anti-Integrin alpha antibody |
|||
| STJ98984 | St John's Laboratory | 200 µl | EUR 197 |
|
Description: Rabbit polyclonal to Integrin alphaE. |
|||
 anti-Integrin alpha 6 |
|||
| YF-PA12761 | Abfrontier | 50 ul | EUR 363 |
|
Description: Mouse polyclonal to Integrin alpha 6 |
|||
|
anti-Integrin alpha 6 |
|||
| YF-PA12762 | Abfrontier | 100 ug | EUR 403 |
|
Description: Rabbit polyclonal to Integrin alpha 6 |
|||
 anti-Integrin alpha 1 |
|||
| YF-PA12784 | Abfrontier | 50 ug | EUR 363 |
|
Description: Mouse polyclonal to Integrin alpha 1 |
|||
 anti-Integrin alpha 4 |
|||
| YF-PA12785 | Abfrontier | 100 ug | EUR 403 |
|
Description: Rabbit polyclonal to Integrin alpha 4 |
|||
 anti-Integrin alpha V |
|||
| YF-PA12786 | Abfrontier | 50 ul | EUR 363 |
|
Description: Mouse polyclonal to Integrin alpha V |
|||
|
anti-Integrin alpha V |
|||
| YF-PA12787 | Abfrontier | 50 ug | EUR 363 |
|
Description: Mouse polyclonal to Integrin alpha V |
|||
|
anti-Integrin alpha V |
|||
| YF-PA12788 | Abfrontier | 100 ug | EUR 403 |
|
Description: Rabbit polyclonal to Integrin alpha V |
|||
|
anti-Integrin alpha 6 |
|||
| YF-PA24004 | Abfrontier | 50 ul | EUR 334 |
|
Description: Mouse polyclonal to Integrin alpha 6 |
|||
|
anti-Integrin alpha 1 |
|||
| YF-PA24011 | Abfrontier | 50 ul | EUR 334 |
|
Description: Mouse polyclonal to Integrin alpha 1 |
|||
|
anti-Integrin alpha 4 |
|||
| YF-PA24013 | Abfrontier | 50 ul | EUR 334 |
|
Description: Mouse polyclonal to Integrin alpha 4 |
|||
 anti-Integrin alpha 9 |
|||
| YF-PA24015 | Abfrontier | 50 ul | EUR 334 |
|
Description: Mouse polyclonal to Integrin alpha 9 |
|||
 anti-Integrin alpha E |
|||
| YF-PA24017 | Abfrontier | 50 ul | EUR 334 |
|
Description: Mouse polyclonal to Integrin alpha E |
|||
 Mouse Anti Human Integrin Alpha V Beta 5 Monoclonal Antibody |
|||
| CABT-49626MH | Creative Diagnostics | 0.1 mg | EUR 1375 |
, Human IgG4 Antibody) Anti-alpha 5 beta 1 Integrin (Volociximab), Human IgG4 Antibody |
|||
| A1092-200 | Biovision | EUR 729 | |
 ELISA Kit) Human Integrin Alpha 5 (ITGa5) ELISA Kit |
|||
| SEB287Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 4502.43 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Integrin Alpha 5 (ITGa5) in Tissue homogenates, cell lysates and other biological fluids. |
|||
|
Human Integrin Alpha 5 (ITGa5) ELISA Kit |
|||
| SEB287Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 458.44 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Integrin Alpha 5 (ITGa5) in Tissue homogenates, cell lysates and other biological fluids. |
|||
|
Human Integrin Alpha 5 (ITGa5) ELISA Kit |
|||
| SEB287Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 612.05 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Integrin Alpha 5 (ITGa5) in Tissue homogenates, cell lysates and other biological fluids. |
|||
|
Human Integrin Alpha 5 (ITGa5) ELISA Kit |
|||
| SEB287Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 2454.23 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Integrin Alpha 5 (ITGa5) in Tissue homogenates, cell lysates and other biological fluids. |
|||
|
Human Integrin Alpha 5 (ITGa5) ELISA Kit |
|||
| 4-SEB287Hu | Cloud-Clone |
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Integrin Alpha 5 (ITGa5) in samples from Tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
 Elisa kit) Human Integrin alpha-5(ITGA5) Elisa kit |
|||
| CSB-E17350h-24T | Cusabio | 1 plate of 24 wells | EUR 165 |
|
Description: Quantitativesandwich ELISA kit for measuring Human Integrin alpha-5 (ITGA5) in samples from serum, plasma, cell culture supernates, urine, cerebrospinalfluid (CSF). A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
|
Human Integrin alpha-5(ITGA5) Elisa kit |
|||
| 1-CSB-E17350h | Cusabio |
|
|
|
Description: Quantitativesandwich ELISA kit for measuring Human Integrin alpha-5(ITGA5) in samples from serum, plasma, cell culture supernates, urine, cerebrospinalfluid(CSF). Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
 Polyclonal Antibody (Human)) Integrin Alpha 5 (ITGa5) Polyclonal Antibody (Human) |
|||
| 4-PAB287Hu01 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Integrin Alpha 5 (ITGa5) |
|||
|
Human Integrin Alpha 5 (ITGa5) ELISA Kit |
|||
| RD-ITGa5-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 500 |
|
Human Integrin Alpha 5 (ITGa5) ELISA Kit |
|||
| RD-ITGa5-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 692 |
 Human ITGA5/ Integrin alpha-5 ELISA Kit |
|||
| E1342Hu | Sunlong | 1 Kit | EUR 605 |
|
Human Integrin Alpha 5 (ITGa5) ELISA Kit |
|||
| DLR-ITGa5-Hu-48T | DL Develop | 48T | EUR 498 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Integrin Alpha 5 (ITGa5) in samples from tissue homogenates, cell lysates or other biological fluids. |
|||
|
Human Integrin Alpha 5 (ITGa5) ELISA Kit |
|||
| DLR-ITGa5-Hu-96T | DL Develop | 96T | EUR 647 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Integrin Alpha 5 (ITGa5) in samples from tissue homogenates, cell lysates or other biological fluids. |
|||
 ELISA Kit) Human Integrin Alpha 5 (ITGA5) ELISA Kit |
|||
| abx571172-96tests | Abbexa | 96 tests | EUR 739 |
 CLIA Kit) Human Integrin Alpha 5 (ITGa5) CLIA Kit |
|||
| 20-abx492595 | Abbexa |
|
|
|
Human Integrin Alpha 5 (ITGa5) ELISA Kit |
|||
| 20-abx151987 | Abbexa |
|
|
